Cargando…
Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878979/ https://www.ncbi.nlm.nih.gov/pubmed/36703211 http://dx.doi.org/10.1186/s40478-023-01518-9 |
_version_ | 1784878604667060224 |
---|---|
author | Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, M. Cristine Johnson, Kenneth L. Pandey, Akhilesh Doles, Jason D. Milone, Margherita |
author_facet | Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, M. Cristine Johnson, Kenneth L. Pandey, Akhilesh Doles, Jason D. Milone, Margherita |
author_sort | Nicolau, Stefan |
collection | PubMed |
description | Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01518-9. |
format | Online Article Text |
id | pubmed-9878979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98789792023-01-27 Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, M. Cristine Johnson, Kenneth L. Pandey, Akhilesh Doles, Jason D. Milone, Margherita Acta Neuropathol Commun Research Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01518-9. BioMed Central 2023-01-26 /pmc/articles/PMC9878979/ /pubmed/36703211 http://dx.doi.org/10.1186/s40478-023-01518-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, M. Cristine Johnson, Kenneth L. Pandey, Akhilesh Doles, Jason D. Milone, Margherita Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title | Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title_full | Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title_fullStr | Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title_full_unstemmed | Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title_short | Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
title_sort | molecular signatures of inherited and acquired sporadic late onset nemaline myopathies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878979/ https://www.ncbi.nlm.nih.gov/pubmed/36703211 http://dx.doi.org/10.1186/s40478-023-01518-9 |
work_keys_str_mv | AT nicolaustefan molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT dasguptaaneesha molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT dasarisurendra molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT charlesworthmcristine molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT johnsonkennethl molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT pandeyakhilesh molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT dolesjasond molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies AT milonemargherita molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies |